Stoke Therapeutics Inc.

STOK | NASDAQ

Price Alert Chart Builder DCF Calculator

$28.05

-$0.38 (-1.34%)

At close: Sep 21, 2026, 4:00 PM ET

$27.96

-$0.09 (-0.32%)

Pre-market: Sep 22, 2026, 8:53 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	184.42M	36.56M	8.78M	12.41M	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	1.93M
Gross Profit	184.42M	36.56M	8.78M	12.41M	n/a	-1.93M
Operating Income	-20.59M	-101.37M	-114.77M	-104.36M	-86.07M	-53.04M
Interest Income	13.77M	12.64M	9.91M	3.12M	120K	744K
Pretax Income	-6.89M	-88.98M	-104.7M	-101.07M	-85.81M	-52.24M
Net Income	-6.89M	-88.98M	-104.7M	-101.07M	-85.81M	-52.24M
Selling & General & Admin	67.09M	48.79M	41.32M	38.92M	31.9M	20.85M
Research & Development	137.92M	89.13M	82.23M	77.84M	54.17M	32.2M
Other Expenses	n/a	n/a	n/a	n/a	n/a	-1.93M
Operating Expenses	205.01M	137.93M	123.55M	116.76M	86.07M	51.12M
Interest Expense	9K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	205.01M	137.93M	123.55M	116.76M	86.07M	53.04M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	59.22M	54.01M	43.99M	38.9M	36.74M	33.49M
Shares Outstanding (Diluted)	59.22M	54.01M	43.99M	38.9M	36.74M	33.49M
EPS (Basic)	-0.12	-1.65	-2.38	-2.60	-2.34	-1.56
EPS (Diluted)	-0.12	-1.65	-2.38	-2.60	-2.34	-1.56
EBITDA	-5.12M	-86.8M	-102.23M	-99.52M	-84.83M	-50.32M
EBIT	-6.89M	-88.98M	-104.7M	-101.07M	-85.81M	-52.24M
Depreciation & Amortization	1.77M	2.18M	2.47M	1.55M	974K	1.93M